Quote:
Originally posted by sgtclub
Allow me be more clear.
* * * * *
And that is the magic link between profits and R&D
|
Thank you. I'm familiar with the accounting terms, actually, but thought you were making some economic claim about why it's important that we not do anything to limit pharma profits. I don't see any reason here to preserve pharma profits, other than the obvious ones.
Quote:
|
You obviously were not reading our conversation closely, but I'll just point out that you ignore in (b) and (c) my contention that it is not just generics that big pharma competes with, but other big pharma with patents for similiar uses, as well as alternative treatments.
|
Of course this is true, to some extent. And yet it fails to answer the thing Burger says and I keep pointing to -- that this industry makes its profits before the generics compete. Since they are (almost) perfect substitutes, this shows that other alternatives are not. Consider again the profit margins on viagra, per Burger. You guys are insisting that there is adequate competition in the face of the specific facts of this industry.
